FDA to Add Tougher Asthma Drug Labels - WSJ.com
Links shared publicly online about this topic.
- 1,372total visits
FDA to Add Tougher Asthma Drug Labels - WSJ.com
The U.S. agency said it plans to implement new 'safety controls' for a class of long-acting asthma drugs. The changes affect Glaxo's Advair and Serevent, Novartis's Foradil and AstraZeneca's Symbicort.
View full resource at online.wsj.com
Tags: COPD Medication, Drug, FDA, Advair, Symbicort, Serevent, Novartis, AstraZeneca
Most Recently Shared on February 18, 2010 at 6:50 pm By:
Big change from FDA. Advair and Symbicort should only be used for the shortest time to achieve control. http://is.gd/8FuPt
Medical News: Labeling Error Prompts Asthma Drug Recall - in Public Health & Policy, FDA General from MedPage Today
medpagetoday.com — “The maker of a nebulized asthma treatment recalled several drug lots due to health hazards posed by erroneous labeling on unit vials.” View full resource at medpagetoday.com
Most Recently Shared on January 4, 2011 at 7:15 pm By:
Medical News: Labeling Error Prompts Asthma Drug Recall - in Public Health & Policy, FDA General from MedPaghttp://t.co/JdCUMPX via @AddThis
Advertisement
